A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cinacalcet
Idelalisib
Naringenin may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Cinacalcet
Sofosbuvir
Naringenin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Cinacalcet
Riociguat
Naringenin may decrease the excretion rate of Riociguat which could result in a higher serum level.
Cinacalcet
Dolutegravir
Naringenin may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Cinacalcet
Afatinib
Naringenin may decrease the excretion rate of Afatinib which could result in a higher serum level.
Cinacalcet
Dabrafenib
Naringenin may decrease the excretion rate of Dabrafenib which could result in a higher serum level.
Cinacalcet
Ponatinib
Naringenin may decrease the excretion rate of Ponatinib which could result in a higher serum level.
Cinacalcet
Vemurafenib
Naringenin may decrease the excretion rate of Vemurafenib which could result in a higher serum level.
Cinacalcet
Teriflunomide
Naringenin may decrease the excretion rate of Teriflunomide which could result in a higher serum level.
Cinacalcet
Pitavastatin
Naringenin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Cinacalcet
Apixaban
Naringenin may decrease the excretion rate of Apixaban which could result in a higher serum level.
Cinacalcet
Pazopanib
Naringenin may decrease the excretion rate of Pazopanib which could result in a higher serum level.
Cinacalcet
Simeprevir
Naringenin may decrease the excretion rate of Simeprevir which could result in a higher serum level.
Cinacalcet
Rivaroxaban
Naringenin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Cinacalcet
Nilotinib
Naringenin may decrease the excretion rate of Nilotinib which could result in a higher serum level.
Cinacalcet
Camptothecin
Naringenin may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Cinacalcet
Alvocidib
Naringenin may decrease the excretion rate of Alvocidib which could result in a higher serum level.
Edrophonium
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ubenimex.
Edrophonium
(S)-Warfarin
The risk or severity of bleeding can be increased when Ubenimex is combined with (S)-Warfarin.
Edrophonium
Tioclomarol
The risk or severity of bleeding can be increased when Ubenimex is combined with Tioclomarol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3